Evaluation of serious adverse drug reactions: A Proactive Pharmacovigilance Program (RADAR) vs safety activities conducted by the Food and Drug Administration and pharmaceutical manufacturers

Charles L. Bennett, Jonathan R. Nebeker, Paul R. Yarnold, Cara C. Tigue, David A. Dorr, June M. McKoy, Beatrice J. Edwards, John F. Hurdle, Dennis P. West, Denys T. Lau, Cara Angelotta, Sigmund A. Weitzman, Steven M. Belknap, Benjamin Djulbegovic, Martin S. Tallman, Timothy M. Kuzel, Al B. Benson, Andrew Evens, Steven M. Trifilio, D. Mark CourtneyDennis W. Raisch

Research output: Contribution to journalArticle

39 Scopus citations

Fingerprint Dive into the research topics of 'Evaluation of serious adverse drug reactions: A Proactive Pharmacovigilance Program (RADAR) vs safety activities conducted by the Food and Drug Administration and pharmaceutical manufacturers'. Together they form a unique fingerprint.

Medicine & Life Sciences